Steele Robert Allan

Director Steele Robert Allan sold 9,815 shares of BJ at $112.21 for $1.1M, reducing holdings 40.3% to 14,536 shares.

Director Steele Robert Allan sold 9,815 shares on 2025-06-03 at $112.21, reducing his stake by 40.3% from 24,351 to 14,536 shares in a $1.1M transaction. The sale occurred near the company's 52-week high of $119.94, with the stock currently trading at $109.06, down 9.1% from that peak and down 9.0% over the past 30 days. While this is a material reduction in director holdings, the trade alone—without disclosed context regarding compensation, estate planning, or other personal circumstances—does not conclusively indicate a forward-looking view of valuation. The company is generating $5.2B in annual quarterly revenue with $149.8M in net income and a P/E of 25.13, reflecting a profitable but relatively premium valuation. The director's cross-ticker track record shows one prior sell with a 30-day return of +9.1%, indicating sales that preceded gains; this same pattern appears in his single prior BJ trade (sell on 2025-03-14 with 30d +9.1%), though 90-day measurement windows are not yet complete for the prior BJ transaction.

Director Steele Robert Allan sold 11,813 shares of BJ at $107.59; retains 24,351 shares post-transaction.

Director Steele Robert Allan executed a discretionary sale of 11,813 shares (11.8K shares) representing a -32.7% reduction in his stake from 36,164 to 24,351 shares. The sale occurred at $107.59, which is 4.3% below the 52-week high of $115.50 and represents entry into a phase where the stock has gained +4.3% over 30 days and +17.2% over 90 days. With BJ trading at a P/E of 27.36 and generating +2.7% annual revenue growth on a $5.1B quarterly revenue base, the sale reflects a material reduction in insider exposure despite the company's recent positive price momentum and continued profitability of $155.7M in the latest quarter.